Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 1;26(13):4036.
doi: 10.3390/molecules26134036.

Curcumin as a Natural Remedy for Atherosclerosis: A Pharmacological Review

Affiliations
Review

Curcumin as a Natural Remedy for Atherosclerosis: A Pharmacological Review

Laxman Singh et al. Molecules. .

Abstract

Curcumin, a natural polyphenolic compound present in Curcuma longa L. rhizomes, shows potent antioxidant, anti-inflammatory, anti-cancer, and anti-atherosclerotic properties. Atherosclerosis is a comprehensive term for a series of degenerative and hyperplasic lesions such as thickening or sclerosis in large- and medium-sized arteries, causing decreased vascular-wall elasticity and lumen diameter. Atherosclerotic cerebro-cardiovascular disease has become a major concern for human health in recent years due to its clinical sequalae of strokes and heart attacks. Curcumin concoction treatment modulates several important signaling pathways related to cellular migration, proliferation, cholesterol homeostasis, inflammation, and gene transcription, among other relevant actions. Here, we provide an overview of curcumin in atherosclerosis prevention and disclose the underlying mechanisms of action of its anti-atherosclerotic effects.

Keywords: atherosclerosis; curcumin; pharmacology; therapeutics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Pharmacological effects and mechanism of action of curcumin in atherosclerosis.

Similar articles

Cited by

References

    1. Hannawi S., Hannawi H., Al Salmi I. Cardiovascular disease and subclinical atherosclerosis in rheumatoid arthritis. Hypertens. Res. 2020;43:982–984. doi: 10.1038/s41440-020-0483-4. - DOI - PubMed
    1. Bi C., Fu Y., Li B. Brain-derived neurotrophic factor alleviates diabetes mellitus-accelerated atherosclerosis by promoting M2 polarization of macrophages through repressing the STAT3 pathway. Cell. Signal. 2020;70:109569. doi: 10.1016/j.cellsig.2020.109569. - DOI - PubMed
    1. Ito K., Maeda T., Tada K., Takahashi K., Yasuno T., Masutani K., Mukoubara S., Arima H., Nakashima H. The role of cigarette smoking on new-onset of chronic kidney disease in a Japanese population without prior chronic kidney disease: Iki epidemiological study of atherosclerosis and chronic kidney disease (ISSA-CKD) Clin. Exp. Nephrol. 2020;24:919–926. doi: 10.1007/s10157-020-01914-8. - DOI - PubMed
    1. Miao J., Zang X., Cui X., Zhang J. Autophagy, Hyperlipidemia, and Atherosclerosis. Adv. Exp. Med. Biol. 2020;1207:237–264. doi: 10.1007/978-981-15-4272-5_18. - DOI - PubMed
    1. Ye J., Wang Y., Wang Z., Liu L., Yang Z., Wang M., Xu Y., Ye D., Zhang J., Zhou Q., et al. The Expression of IL-12 Family Members in Patients with Hypertension and Its Association with the Occurrence of Carotid Atherosclerosis. Mediat. Inflamm. 2020;2020:2369279. doi: 10.1155/2020/2369279. - DOI - PMC - PubMed